Accordingly, the overall aim of our work was a detailed analysis of the association of LOX mRNA expression and the G473A SNP with clinically relevant properties of human breast cancer such as prognosis, age at onset, and clinical and histopathological characteristics of routine breast cancer categorization and staging such as the ER status. Here, LOX is linked to breast carcinoma.